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Abstract
Background
National guidelines (NICE-CG175) recommended 12 weeks of supervised exercise training
for men treated with androgen deprivation therapy (ADT) for prostate cancer to counter
debilitating adverse effects of castration. As with other chronic conditions where exercise is
indicated, it is uncertain if these services are being delivered in the health services. The aim
of this multi-centre investigation was to examine what exercise referral is currently available
for men on ADT as provided by the NHS and if a supervised, individually-tailored exercise
training package (as per the national NICE guidelines CG175) is embedded within prostate
cancer care.
Methods
A multi-centre investigation of current National Health Service (NHS) care involving a web-
based survey of NHS prostate cancer care, five focus groups involving 26 men on ADT and
37 semi-structured interviews with healthcare professionals (HCPs) involved in the manage-
ment of prostate cancer. Descriptive statistics and thematic analysis evaluated quantitative
and qualitative data, respectively. Qualitative methods followed COREQ standards.
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Results
HCPs and men on ADT asserted that medical castration has a serious and debilitating
impact on many features of men’s quality of life. There is support for exercise training pro-
grammes as part of cancer care and patients would support their initiation soon after diagno-
sis. Involving the Multidisciplinary Team (MDT) is proposed as key to this. Critically,
traditional values in oncology would need to be overcome for widespread acceptance. Spe-
cialist further training for HCPs around behaviour change support could encourage this.
Given that these schemes are seen as a fundamental part of cancer care, it is felt the NHS
should commission and support provision. 79 representatives of 154 NHS trusts (51%) pro-
vided survey data on current delivery: only 17% could provide supervised exercise as per
CG175.
Conclusions
Evidence-based national exercise guidelines are not being delivered to men on ADT as
intended. Traditional values in oncology and the need for NHS financial support are seen as
major barriers to provision of current best practice guidelines. Despite this both HCPs and
men on ADT are in favour of such programmes being a fundamental part of their cancer
care.
Introduction
In 2014, approximately 47,000 men were newly diagnosed with prostate cancer in the UK,
with 11,000 resultant deaths per annum.[1] Androgen deprivation therapy (ADT)[2] is stan-
dard treatment in the NHS[3] delivered neo-adjuvantly with radiotherapy for localised and
locally advanced disease and as monotherapy for metastatic disease (more recently in combi-
nation with taxane-based chemotherapy).[4] Around one half of men with prostate cancer will
undergo such treatment.[5] Given current incidence data for prostate cancer it is likely that
around 20,000 men are initiated on ADT annually and approximately 125,000 men in the UK
will be maintained on ADT this year. It is estimated that by 2020 and 2030 this will be over
200,000 and 300,000 men respectively.[6]
ADT adversely impacts quality of life (QoL) causing fatigue, reduced muscle mass, sexual
problems, and increases risk of fracture and acute kidney injury.[5,7–14] In men with
advanced prostate cancer the prevalence of dementia, depression, anxiety or psychosis is
around 1 in 4.[15] Furthermore, long-term ADT has been linked with worsening cardiovas-
cular health.[16] This is of concern as men with prostate cancer already constitute a high-
risk population for cardiovascular disease.[17] As well as the distress and loss of QoL to the
individual, these side-effects place additional burden on healthcare services and support
networks.
Unmet needs and ongoing support requirements from men diagnosed with prostate cancer
are established.[18,19] Numerous strategies for managing side-effects are tried in practice, but
exercise training is the only evidence-based supportive therapy for improving disease-specific
QoL in men on ADT [20,21]. The National Institute for Health and Care Excellence (NICE) in
the UK (NICE-CG175) and the European Association of Urology (EAU) have both recom-
mended supervised exercise training as part of standard treatment for men with prostate can-
cer on long-term ADT.
Exercise training in clinical practice for men on ADT
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The aim of this multi-centre investigation was to examine what exercise referral is currently
available for men on ADT as provided by the NHS and if a supervised, individually-tailored
exercise training package (as per the national NICE guidelines CG175) is embedded within
prostate cancer care.
Materials and methods
UK NHS (15/SW/0260) and University ethical boards provided approval for this study. The
programme of work consisted of 3 components:, semi-structured interviews with healthcare
professionals (HCPs), focus groups with men with prostate cancer on ADT and a national
online survey of members of stakeholder organisations involved in the delivery of prostate can-
cer care.
Methods for qualitative reporting were guided by the COREQ standards [22] (S1 File).
Interview and focus group participants were recruited between August 2015 and June 2016:
written informed consent was obtained from participants.
Semi-structured interviews
Semi-structured qualitative interviews were conducted with HCPs recruited via professional
organisations and local authority employees working in diverse roles representing different
disciplines within the NHS prostate cancer care and exercise referral pathway (see Table 1).
Interviews (n = 37) were conducted either face-to-face (n = 7) or by telephone (n = 30) and
lasted between 20 and 50 minutes. Interviews covered inter alia HCP roles, adverse effects of
ADT, awareness, and practice with respect to the recent national (NICE-CG175) guidelines,
problems with offering structured exercise programmes in standard care and the need for fur-
ther education/training of HCPs (S2 File).
Focus groups
Focus groups were facilitated by members of the research team supported by a patient repre-
sentative. Twenty-six men with prostate cancer on ADT for at least 6 months were recruited
from urology out-patients departments at the Royal Hallamshire and Chesterfield Royal Hos-
pitals (approached by the research team during routine follow-up, from prostate cancer
Table 1. Characteristics of healthcare professionals participating in interviews.
Profession Consultant Urologist 24.3% (9)
Oncologist 27% (10)
Clinical Nurse Specialist 16.2% (6)
General Practitioner 8.1% (3)
Physiotherapist 8.1% (3)
Exercise Specialist 5.4% (2)
Service Manager 2.7% (1)
Clinical Commissioner 8.1% (3)
Primary Care Physician 2.7% (1)
Institution Teaching Hospital 24.3% (9)
District Hospital 18.9% (7)
University 2.7% (1)
Community 13.5% (5)
Cancer centre 29.7% (11)
Primary Care 10.8% (4)
https://doi.org/10.1371/journal.pone.0197606.t001
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support groups, or via recruitment posters). See Table 2 for details. Study information was
posted to the homes of men who expressed an interest, and phone calls were made after 24
hours of them receiving this information to invite them to a group. Participants completed a
demographic questionnaire, the Godin Leisure-Time Exercise Questionnaire[23] and WHO-
DAS II Questionnaire[24],upon arrival.
During the focus groups (S3 File) discussions firstly centred around physical activity and
experiences of prostate cancer, followed by more in-depth questions regarding QoL and views
Table 2. Focus group characteristics.
Age (yrs) 55–59 7.7% (2)
60–69 38.5% (10)
70–79 38.5% (10)
80–89 15.4% (4)
Ethnicity White British 96.2% (25)
African/ Afro-Caribbean origin 3.8% (1)
Educational status Degree or other higher education 26.9% (7)
‘A’ level or equivalent in other country 14.3% (4)
GSCE or equivalent in other country 7.7% (2)
Other qualification 10.7% (3)
No formal qualification 35.7% (10)
Marital Status Married or living with partner 80.8% (21)
Divorced or separated 11.5% (3)
Widowed 7.7% (2)
Employment status Full time employment 7.7% (2)
Self-employment 7.7% (2)
Retired 64.3% (18)
Voluntary Work 3.8% (1)
Sick or disabled 3.8% (1)
Other 7.7% (2)
Length of diagnosis <6 months 7.7% (2)
6 months– 3 years 50.0% (13)
3–5 years 15.4% (4)
5+ years 26.9% (7)
Length of ADT <6 months 7.7% (2)
6 months– 3 years 65.4% (17)
3–5 years 15.4% (4)
5+ years
Need to add up to 26 or add in ‘missing’
11.5% (3)
Co-morbidities reported High Blood pressure 7
Type 2 diabetes 3
Respiratory 6
Cardiac 4
Arthritis 1
Colitis 3
Other 4
Musculoskeletal/ spinal 3
None 6
11 men reported more than one co-morbidity
https://doi.org/10.1371/journal.pone.0197606.t002
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on exercise training as a way to manage side-effects of ADT. The practicalities of accessing an
integrated exercise programme were also debated. Adverse effects of ADT and coping styles
were discussed within the groups to understand how exercise might be embedded in standard
care. All focus groups and interview participants provided informed consent.
Electronic survey
We contacted (via email) HCPs working in NHS prostate cancer care (see Table 3) through
their professional bodies (British Association of Urological Nurses, British Association of Uro-
logical Surgeons, British Uro-Oncology Group, Primary Care Urology Society) and commis-
sioners via clinical leads and accountable officers of all Clinical Care Groups (CCG) in
England and requested they complete an electronic survey of their current practice activity (S4
File). The questionnaire was developed and refined in partnership with a dedicated study
patient and public involvement panel. Any missing or incomplete survey responses were sup-
plemented by data from local provider webpages and follow-up letters, phone calls and emails.
Letters were also sent to all CCGs within England. Links to our survey were also advertised to
health care professionals on the social media site, Twitter.
Analysis
Interviews and focus groups were recorded digitally and transcribed verbatim. Data were ana-
lysed using a thematic framework approach [25] with the aid of NVIVO software. Transcripts
were double coded by study researchers. Key themes and sub-themes were identified. To
determine variance in exercise training provision, two independent investigators rated the sur-
vey data by location in regards to likelihood of providing exercise services according to NICE
guidance. Key indicators were: availability of local exercise referral schemes, multi-disciplinary
team working, access to specialists in exercise prescription, supervised exercise provision, par-
allel behaviour change services and any specialist staff training programmes: please see Fig 1.
The locations were mapped by postcode (ArcMap software v.10.2) using graduated symbols
(circles) with a combination of size and colour indicating the grading.
Results
i. Semi-structured interviews with HCPs
Table 4 contains the full list of themes and sub themes arising from the 37 HCP interviews. For
the purposes of brevity and clarity, key themes related to exercise provision with illustrative
Table 3. Survey respondent’s profession.
Profession n
Allied Health Care Professional 3
Cancer Care Commissioner 3
Exercise Physiologist 3
General Care Commissioner 1
General Practitioner (GP) 7
Nurse 20
Oncologist 4
Physiotherapist 3
Urologist 35
Other 16
Total 95
https://doi.org/10.1371/journal.pone.0197606.t003
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quotes are detailed below. All qualitative data used to construct themes and sub-themes can be
found in S5 File.
Impact of ADT: QoL. ADT was widely acknowledged as having significant adverse effects
on social functioning and general QoL. A particular aspect that was identified was the impact
on physical ability.
“. . . it’s overwhelming and life-changing and devastating.” (CNS)
“. . .my patients . . . a lot of them were builders—they say that they don’t do the heavy work
anymore” (ONC)
Fig 1. The distribution of survey respondents across the UK based on investigator-rated scores. The blue (larger)
circles indicate locations with good (15–19 score) or moderate (10–14 score) capability to deliver exercise training
according to NICE CG175.The (smaller) red circles indicate no (0–4 score) or limited (5–9 score) ability to deliver exercise
training according to NICE CG175.
https://doi.org/10.1371/journal.pone.0197606.g001
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Embedding in the NHS: Delivery of a supervised exercise training programme. Suc-
cessful delivery of a prostate cancer specific exercise training programme as per the guidelines
(NICE-CG175) was considered dependent upon having HCPs with the necessary skills. These
include experience of exercise prescription, supervision and dealing with any comorbidities, to
allow tailoring of the exercises to the individual’s needs and abilities. There was a general lack
of consensus as to who could fulfil this role.
“. . . I think the actual assessing and doing the intervention should probably be, I would say,
a physiotherapist probably because I am a physiotherapist.” (PHY)
“I’m not sure it’s quite the physiotherapist’s role . . .somewhere between a personal trainer
and someone . . . at the leisure centre doing exercise classes and things.” (URO)
Table 4. All interview themes and sub-themes.
Themes Sub themes
Impact of ADT Side Effects
Quality of Life (QoL) and Coping
New NICE guidelines on exercise for men on ADT in the NHS Awareness
Standard of care
Level of Conviction
Clinical effectiveness
Perceived benefits and purpose
General Physical and Mental Health
Management of Side-effects
Embedding in the NHS Delivery of Programme
Referral
MDT Role
Setting
Feedback
Evidence Base
Championing
Awareness of exercise programmes
Commissioning Cost-Effectiveness
HCP Barriers Referral process
Resources
Competencies
Traditional Values
Potential solutions Evidence Base
Specialist further training
Patient Barriers Impact of treatment
Information Giving
Worries and concerns
Practicalities
Potential solutions Necessity
Support
Organisational barriers Funding
Resources
HCP Training Practicalities
Commitment
Skills training
Behaviour change and communication
Referral Process
Awareness
https://doi.org/10.1371/journal.pone.0197606.t004
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“I think someone with an interest . . . in this whole health benefit thing, and it could be a
physio, could be a CNS.” (URO)
Embedding in the NHS: Role of the MDT. Integrating of exercise training within the
MDT discussion of the care package was highlighted as a priority, without which successful
implementation would be unlikely.
“Let’s get serious on it (sic exercise training),. . . every place should be having a robust lead
running MDT, ok. No place in this country should say that they don’t have an effective
MDT.” (ONC)
Commissioning: Cost-effectiveness. There was uncertainty as to whether exercise pro-
grammes for prostate cancer should receive funding from the NHS (cf ADT/chemotherapy). It
was considered essential that these programmes should be embedded within the core service.
Systemic benefits of exercise could make it cost-effective, given potential benefits in reducing
psychological or cardiovascular complications of ADT.
“I think unfortunately the pragmatic side of it is unlikely that the NHS would be able to
kind of fund all of it . . .” (CNS)
“I mean, if there’s provision for a charity or if there’s provision for any money by the NHS
that’s going to be . . . so if it’s still free to the patient, I’d rather tap into it because you know,
we’re in austerity at the moment . . .” (URO)
“And it’s not just going to help with fatigue, it’s going to help psychologically. So perhaps
referrals onto our clinical psychologist which probably costs a fortune cos they’ll come
down.”(CNS)
“. . .we won’t have to perhaps see them so often because they’ll feel better about themselves
maybe; it’ll reduce phone calls—we get a loads of patient phone calls, you know, just need-
ing a bit of reassurance over the phone.” (CNS)
HCP barriers: Traditional values. It was considered that clinicians might be quite con-
servative as to the possible benefits of exercise training, particularly in elderly patients with
metastatic cancer. These values were considered a potential barrier the integration of exercise
training in standard treatment.
“I mean for some people, the idea to put 80-year old people on treadmills is close to torture
. . .” (GP)
“You may get certain, you know, some doctors who just maybe don’t see the value of it.”
(CNS)
HCP Training: Behaviour change and communication. The importance of educating
HCPs in behaviour change techniques, including specific approaches such as motivational
interviewing, were highlighted as key to enabling integration of exercise training into the stan-
dard clinical pathway.
“I probably would need to do a little bit more work into behavioural change to look at really
how you guide someone as expertly as possible to make positive health changes . . .” (PHY)
Exercise training in clinical practice for men on ADT
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“So you have to have the ability to do that. I don’t think any healthcare professional could
do that without, certainly not without training at least.” (PHY)
ii. Focus groups
The age range of participants was between 58–84 years. The majority were of white British eth-
nicity (96%), which was broadly reflective of the local population. The mean duration of ADT
was 2.3 years (SD = 0.8). A number of the men suffered with comorbidities such as arthritis,
hypertension, cardiac disease and diabetes. Godin Leisure-Time Exercise Questionnaire
mean = 24.3 (SD = 21.4) and WHODAS II Questionnaire score mean = 14.4 (SD = 15.1).
Table 5 outlines the main themes arising from the 5 focus groups involving 26 men on
ADT for prostate cancer. Illustrative quotes are provided for more detail below.
Experience of hormone therapy: Adverse effects and impact on QoL. A wide range of
adverse effects were reported. The most common included weight gain, hot flushes, fatigue,
sexual dysfunction, the need to urinate more frequently and emotional lability.
“I hate it with an absolute passion. It’s because it’s changed my personality so much.”
“Hot flushes do make you tired. It shattered me completely.”
“I’m an emotional wreck. I’m not the person that my partner was marrying into.”
“Well, no sex for starters . . .”
Adherence: Barriers. Physical activity levels varied amongst individuals, but all the men
stated that they would like to be more active. Co-morbidities, pain, fear of injury and lack of
physical fitness were mentioned as barriers to exercise.
“But I’m wary now of falling over.”
“It’s not through lack of wanting to, . . . I’ve got half the haemoglobin floating around in my
body.”
“I’m slightly out of sync, because at the moment I’m having chemotherapy and the chemo
tends to have significant effects every three weeks. So I find there’s times where I just don’t
do very much at all and the steroids kind of make me put weight on.”
Table 5. All focus groups themes and sub-themes.
Themes Sub themes
Experience of hormone therapy Adverse effects of hormone therapy
Impact upon QoL
Impact upon identity
Coping Approach coping style
Avoidant coping style
Value of physical activity Side-effects of hormone therapy
Adherence to exercise programmes Barriers
Solutions
Patient centred design of exercise schemes Social contact
Referral process
Information giving
Delivery
Emotional support
https://doi.org/10.1371/journal.pone.0197606.t005
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Adherence: Solutions. Social interactions within group training sessions were seen as
potentially important factors to help improve uptake and adherence rates of an exercise pro-
gramme. Tailoring was seen as essential, particularly in men with other co-morbidities.
“In my opinion, it’s better in a group. I know some people like to do it individually, but
from personal experience, it’s better in a group . . .”
“The key thing that would make me engage with it, is if it was individualised to me . . .”
Patient centred design: Referral process. The timing of referral was viewed as crucial.
Views were mixed on when the programme should be offered to the men, however, it was
agreed it should not be offered at the end of treatment. Offering a referral onto an exercise pro-
gramme as soon as treatment is initiated was broadly supported.
“If exercise is proven to be beneficial to prostate cancer, then it’s beneficial as soon as you
diagnose it.”
Whereas having a period of time to “digest” the diagnosis and information, then having
access to the programme which would continue whilst they were receiving treatment felt more
appropriate to some men:
“To answer your question, I’d rather on being diagnosed, find out what treatment they’re
going to give me. Let me settle down a bit, let me come to terms with where I am and how
I’m going to handle it, from both a personal and the family and wider circle of friends.”
The men felt that it was the consultant’s job to broach the subject of exercise initially, mak-
ing them aware of the benefits of being active and making it specific to prostate cancer Having
the appropriate written information on the benefits of exercise to support this and information
on the programme itself would also be necessary. Further advice would be preferred to be
given face to face by the nurse practitioner, with the nurse practitioner being responsible for
going through any worries or concerns the men had. Being “sold” the exercise by the consul-
tants, and the nurse practitioners would be best placed to provide encouragement:
“Yes, I agree with that. You have to be sold because you’ve been hit by the fact that you’ve
got cancer and you need somebody to actually sell it and say “Look, we think this is going
to work for you. I think you should try these exercises”.”
iii. Electronic survey
A total of 95 responders from 79/154 NHS trusts provided data (51%). Anonymised survey
response data and investigator ratings can be found in S6 File. From these 95 responses, 38
unique locations were rated as ‘moderately’ or ‘highly’ capable of delivering the NICE recom-
mendation. Integrated descriptions of these sites based on survey data, interviews and follow-
up phone calls can be found in S7 File. From follow-up phone calls to CCGs, HCPs and com-
munity exercise providers, a further 9 such locations were identified and rated, giving a total of
47 locations. NHS professionals and non-NHS sources provided 31 and 16 of these locations,
respectively. Fig 1 depicts the distribution of these sites geographically. There is variability in
duration, frequency and delivery with supervision of any kind being provided in 25 (53%) and
twice-weekly supervised sessions in 8 (17%). Schemes lasting 12 weeks or more are reported
by 24 (51%) and involvement of an ‘exercise specialist’ in the delivery in 21 (45%). There are
Exercise training in clinical practice for men on ADT
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only three prostate cancer-specific programmes and two of these described the exercise provi-
sion as being integrated into the usual prostate cancer care pathway.
Discussion
Our data indicates there is minimal evidence that integration and provision of exercise train-
ing as per NICE CG175 is happening in practice. Whilst there is enthusiasm around exercise
for men on ADT, HCPs involved in the prostate cancer care pathway find implementation of
these guidelines problematic. The development of specialised education/training packages for
HCPs for supporting exercise training and also the development of the evidence base were
identified as factors requiring attention. Men on ADT asserted that their treatment does
indeed have negative consequences on quality of life and that they would be enthusiastic about
the provision of exercise training to address some of these issues. Any such service would need
to be tailored to individual capabilities and existing co-morbidities.
It is important to acknowledge some key limitations of these analyses. The recruitment pro-
cedure did not allow us to calculate response rates for the survey as professional bodies acted
as intermediaries in the identification process. We are not aware of any other recent studies
undertaking similar analyses in the UK and as such these results provide unique data around
the question of exercise provision for men on ADT according to the most recent iteration of
the NICE guidelines. In addition, we relied on respondents to be a member of professional
bodies or groups and to be actively reading emails from the group, which might have biased
the sampling. We did not survey private sector providers, cancer related charities or voluntary
agencies that might provide exercise referral schemes for people with cancer. Survey data from
only 51% of NHS trusts could introduce the possibility of selection bias.
The provision of exercise therapy for long-term conditions is not a new concept. Exercise
rehabilitation/training for cardiovascular disease is a useful comparison.[26] Meta analyses of
randomised trials have reported benefits in terms of better overall mortality and cardiovascular
mortality and reduced risk of hospital admission.[27,28] However, the delivery of exercise
training with the fidelity that would reproduce the benefits reported in the clinical studies in
NHS service is not a reality. Serious problems around staffing levels, multi-disciplinary
involvement, exercise prescription (frequency, intensity and duration), parallel behaviour
change support and the method of exercise delivery have been highlighted by senior academics
leading the National Audit of Cardiac Rehabilitation.[29] Crucially, less than 5% of pro-
grammes in the UK state that they have a doctor as part of the multi-disciplinary team. With
this fundamental lack of embedding of exercise services in core cardiac care, it is easy to see
how they can become an afterthought and sub-optimally implemented (where done at all).
Men with prostate cancer consistently report unmet needs.[18] Previous analysis of pro-
spective data taken from NHS services has highlighted that unmet needs in cancer survivors
tend to stay unmet.[30] Despite the publication of this data (which is over a decade old), it is
unclear where the innovation in cancer care pathways has taken place in the NHS—there are
certainly very few multi-centre trials of supportive survivorship therapies that have provided
both clinical and cost-effectiveness data. This is despite two key government policy documents
in 2011 and 2015 highlighting the increasing importance of cancer survivorship.[31,32] Inde-
pendent reports from CRUK assessing the implementation of the UK’s cancer strategies sug-
gests that whilst cancer survivorship issues are broadly better appreciated in the NHS,
dedicated services are seen as ’soft’ and tend to be viewed as lower priority and particularly vul-
nerable in ’challenging financial climates’.[33] Indeed, it is often left to specialist cancer chari-
ties to fund enhanced cancer survivorship services including exercise referral services.
Exercise training in clinical practice for men on ADT
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Conclusion
There is substantial variability in exercise training delivery across the UK, with little provision
available in line with the NICE guidance (CG175). Men on ADT for prostate cancer should be
supported through treatment with dedicated, supervised exercise training and where available
clinical teams should be making the appropriate referrals for their patients. Further research is
likely needed to explore how to embed these services where referrals are not already happening.
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